Home Virtual Reality Hand Training for People With Multiple Sclerosis
Tests home virtual reality headset hand-skill training in adults with multiple sclerosis.
Plain-language title generated from the registry record
Registry title: VR-based Dexterity Training in MS
Key facts
- Where
- Basel and Lucerne, SwitzerlandSee the 2 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 75 years old?
Source: NCT07193602, who can take part
Where in Switzerland
- MS Centre, Neurology, University hospital BaselBasel, SwitzerlandNo longer taking part
- Lucerne Cantonal HospitalLucerne, SwitzerlandNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Christian Kamm
- Trial code
- NCT07193602
- Record updated
- 13 April 2026
- Original description
The aim of the study is to investigate if a specifically developed home-based dexterity training intervention using a Virtual Reality (VR) Headset (Meta quest 2) improves impaired manual dexterity in persons with multiple sclerosis.Read full original descriptionShow less
Home-based Virtual Reality (VR) Headset-based Dexterity Training in Multiple Sclerosis: a Randomized-controlled Trial
The aim of the study is to investigate if a specifically developed home-based dexterity training intervention using a Virtual Reality (VR) Headset (Meta quest 2) improves impaired manual dexterity in persons with multiple sclerosis.
Inclusion: MS patients with relapsing-remitting MS (RRMS), secondary-progressive MS (SPMS) or primary progressive MS (PPMS) according to the revised McDonald's criteria (Thompson et al. 2017); Age between 18 and 75 years; Written informed consent signed by the subject must be obtained prior to study start; Patient must complain about MS related impaired manual dexterity negatively affecting ADL and/or QoL; Patients must have Arm function in multiple sclerosis questionnaire (AMSQ) score >41.
Exclusion: A relapse that started within 60 days prior to screening; A history of drug abuse in the 12 months prior to screening; Rapidly progressive disease; Any disease/condition that impaired manual dexterity besides MS; Any disease other than MS that could possibly explain the patient's signs and symptoms; Medical or psychiatric conditions that compromise the ability to comply with the protocol, or to complete the study; History of epilepsy or epileptic seizures.